144 related articles for article (PubMed ID: 16733518)
1. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
White KA; Lange EM; Ray AM; Wojno KJ; Cooney KA
Prostate Cancer Prostatic Dis; 2006; 9(3):298-302. PubMed ID: 16733518
[TBL] [Abstract][Full Text] [Related]
2. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.
Zuhlke KA; Madeoy JJ; Beebe-Dimmer J; White KA; Griffin A; Lange EM; Gruber SB; Ostrander EA; Cooney KA
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5975-80. PubMed ID: 15447980
[TBL] [Abstract][Full Text] [Related]
3. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
[TBL] [Abstract][Full Text] [Related]
4. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
Grönberg H; Xu J; Smith JR; Carpten JD; Isaacs SD; Freije D; Bova GS; Danber JE; Bergh A; Walsh PC; Collins FS; Trent JM; Meyers DA; Isaacs WB
Cancer Res; 1997 Nov; 57(21):4707-9. PubMed ID: 9354426
[TBL] [Abstract][Full Text] [Related]
5. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
6. Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees.
Camp NJ; Farnham JM; Cannon-Albright LA
Cancer Res; 2006 Oct; 66(20):10205-12. PubMed ID: 17047086
[TBL] [Abstract][Full Text] [Related]
7. Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer.
Johanneson B; Deutsch K; McIntosh L; Friedrichsen-Karyadi DM; Janer M; Kwon EM; Iwasaki L; Hood L; Ostrander EA; Stanford JL
Prostate; 2007 May; 67(7):732-42. PubMed ID: 17372923
[TBL] [Abstract][Full Text] [Related]
8. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Mar; 62(6):1784-9. PubMed ID: 11912155
[TBL] [Abstract][Full Text] [Related]
9. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.
Paris PL; Witte JS; Kupelian PA; Levin H; Klein EA; Catalona WJ; Casey G
Cancer Res; 2000 Jul; 60(13):3645-9. PubMed ID: 10910080
[TBL] [Abstract][Full Text] [Related]
10. Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families.
Bochum S; Paiss T; Vogel W; Herkommer K; Hautmann R; Haeussler J
Prostate; 2002 Jun; 52(1):12-9. PubMed ID: 11992616
[TBL] [Abstract][Full Text] [Related]
11. The complex genetic epidemiology of prostate cancer.
Schaid DJ
Hum Mol Genet; 2004 Apr; 13 Spec No 1():R103-21. PubMed ID: 14749351
[TBL] [Abstract][Full Text] [Related]
12. R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
Gruber SB; Chen H; Tomsho LP; Lee N; Perrone EE; Cooney KA
Prostate; 2003 Mar; 54(4):306-9. PubMed ID: 12539229
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations in fumarate hydratase (FH) do not predispose to prostate cancer.
Bevan S; Edwards SM; Ardern Jones A; Dowe A; Southgate C; Dearnaley D; Easton DF; Houlston RS; Eeles RA;
Prostate Cancer Prostatic Dis; 2003; 6(1):12-4. PubMed ID: 12664059
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancer.
Chang BL; Gillanders EM; Isaacs SD; Wiley KE; Adams T; Turner AR; Zheng SL; Meyers DA; Carpten JD; Walsh PC; Trent JM; Xu J; Isaacs WB
Cancer Lett; 2005 Mar; 219(2):177-82. PubMed ID: 15723717
[TBL] [Abstract][Full Text] [Related]
15. A genomewide linkage analysis for prostate cancer susceptibility genes in families from Germany.
Maier C; Herkommer K; Hoegel J; Vogel W; Paiss T
Eur J Hum Genet; 2005 Mar; 13(3):352-60. PubMed ID: 15536476
[TBL] [Abstract][Full Text] [Related]
16. A candidate prostate cancer susceptibility gene at chromosome 17p.
Tavtigian SV; Simard J; Teng DH; Abtin V; Baumgard M; Beck A; Camp NJ; Carillo AR; Chen Y; Dayananth P; Desrochers M; Dumont M; Farnham JM; Frank D; Frye C; Ghaffari S; Gupte JS; Hu R; Iliev D; Janecki T; Kort EN; Laity KE; Leavitt A; Leblanc G; McArthur-Morrison J; Pederson A; Penn B; Peterson KT; Reid JE; Richards S; Schroeder M; Smith R; Snyder SC; Swedlund B; Swensen J; Thomas A; Tranchant M; Woodland AM; Labrie F; Skolnick MH; Neuhausen S; Rommens J; Cannon-Albright LA
Nat Genet; 2001 Feb; 27(2):172-80. PubMed ID: 11175785
[TBL] [Abstract][Full Text] [Related]
17. Genetic linkage of prostate cancer risk to the chromosome 3 region bearing FHIT.
Larson GP; Ding Y; Cheng LS; Lundberg C; Gagalang V; Rivas G; Geller L; Weitzel J; MacDonald D; Archambeau J; Slater J; Neuberg D; Daly MB; Angel I; Benson AB; Smith K; Kirkwood JM; O'Dwyer PJ; Raskay B; Sutphen R; Drew R; Stewart JA; Werndli J; Johnson D; Ruckdeschel JC; Elston RC; Krontiris TG
Cancer Res; 2005 Feb; 65(3):805-14. PubMed ID: 15705877
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients.
Sun J; Lange EM; Isaacs SD; Liu W; Wiley KE; Lange L; Gronberg H; Duggan D; Carpten JD; Walsh PC; Xu J; Chang BL; Isaacs WB; Zheng SL
Prostate; 2008 Apr; 68(5):489-97. PubMed ID: 18213635
[TBL] [Abstract][Full Text] [Related]
19. Linkage of aggressive prostate cancer to chromosome 7q31-33 in German prostate cancer families.
Paiss T; Wörner S; Kurtz F; Haeussler J; Hautmann RE; Gschwend JE; Herkommer K; Vogel W
Eur J Hum Genet; 2003 Jan; 11(1):17-22. PubMed ID: 12529701
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
